Abstract
Summary
Electrophoresis is a technique used to separate DNA, RNA, and proteins using an electrical current based on the molecular weight or fragment size. The electrophoresis reagents being used in the electrophoresis technique are known as electrophoresis reagents. This technology is widely used in the fields of medical diagnostics and life sciences and clinical research.
LPI (LP Information)' newest research report, the “Nucleic Acid Electrophoresis and Blotting Industry Forecast” looks at past sales and reviews total world Nucleic Acid Electrophoresis and Blotting sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Electrophoresis and Blotting sales for 2023 through 2029. With Nucleic Acid Electrophoresis and Blotting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Electrophoresis and Blotting industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Electrophoresis and Blotting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Electrophoresis and Blotting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Electrophoresis and Blotting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Electrophoresis and Blotting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Electrophoresis and Blotting.
The global Nucleic Acid Electrophoresis and Blotting market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid Electrophoresis and Blotting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Electrophoresis and Blotting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Electrophoresis and Blotting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Electrophoresis and Blotting players cover Bio-Rad, Agilent Technologies, BioAtlas, Cytiva, Lonza Group, Merck KGaA, Qiagen, Takara Bio and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Electrophoresis and Blotting market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic Acid Electrophoresis Reagents
Nucleic Acid Electrophoresis Apparatus
Software
Others
Segmentation by application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Forensic Laboratories
Hospitals and Diagnostics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Agilent Technologies
BioAtlas
Cytiva
Lonza Group
Merck KGaA
Qiagen
Takara Bio
Thermo Fisher Scientific
Promega Corporation
Hoefer
Sebia Group
Randox Laboratories
Helena Laboratories Corporation
ELITechGroup
LabRepCo
Abcam
LPI (LP Information)' newest research report, the “Nucleic Acid Electrophoresis and Blotting Industry Forecast” looks at past sales and reviews total world Nucleic Acid Electrophoresis and Blotting sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Electrophoresis and Blotting sales for 2023 through 2029. With Nucleic Acid Electrophoresis and Blotting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Electrophoresis and Blotting industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Electrophoresis and Blotting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Electrophoresis and Blotting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Electrophoresis and Blotting market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Electrophoresis and Blotting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Electrophoresis and Blotting.
The global Nucleic Acid Electrophoresis and Blotting market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid Electrophoresis and Blotting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Electrophoresis and Blotting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Electrophoresis and Blotting is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Electrophoresis and Blotting players cover Bio-Rad, Agilent Technologies, BioAtlas, Cytiva, Lonza Group, Merck KGaA, Qiagen, Takara Bio and Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Electrophoresis and Blotting market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Nucleic Acid Electrophoresis Reagents
Nucleic Acid Electrophoresis Apparatus
Software
Others
Segmentation by application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Forensic Laboratories
Hospitals and Diagnostics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Agilent Technologies
BioAtlas
Cytiva
Lonza Group
Merck KGaA
Qiagen
Takara Bio
Thermo Fisher Scientific
Promega Corporation
Hoefer
Sebia Group
Randox Laboratories
Helena Laboratories Corporation
ELITechGroup
LabRepCo
Abcam
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Electrophoresis and Blotting Market Size 2018-2029
2.1.2 Nucleic Acid Electrophoresis and Blotting Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nucleic Acid Electrophoresis and Blotting Segment by Type
2.2.1 Nucleic Acid Electrophoresis Reagents
2.2.2 Nucleic Acid Electrophoresis Apparatus
2.2.3 Software
2.2.4 Others
2.3 Nucleic Acid Electrophoresis and Blotting Market Size by Type
2.3.1 Nucleic Acid Electrophoresis and Blotting Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nucleic Acid Electrophoresis and Blotting Market Size Market Share by Type (2018-2023)
2.4 Nucleic Acid Electrophoresis and Blotting Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Academic and Research Institutions
2.4.3 Forensic Laboratories
2.4.4 Hospitals and Diagnostics
2.4.5 Other
2.5 Nucleic Acid Electrophoresis and Blotting Market Size by Application
2.5.1 Nucleic Acid Electrophoresis and Blotting Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nucleic Acid Electrophoresis and Blotting Market Size Market Share by Application (2018-2023)
3 Nucleic Acid Electrophoresis and Blotting Market Size by Player
3.1 Nucleic Acid Electrophoresis and Blotting Market Size Market Share by Players
3.1.1 Global Nucleic Acid Electrophoresis and Blotting Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Electrophoresis and Blotting Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Electrophoresis and Blotting Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nucleic Acid Electrophoresis and Blotting by Regions
4.1 Nucleic Acid Electrophoresis and Blotting Market Size by Regions (2018-2023)
4.2 Americas Nucleic Acid Electrophoresis and Blotting Market Size Growth (2018-2023)
4.3 APAC Nucleic Acid Electrophoresis and Blotting Market Size Growth (2018-2023)
4.4 Europe Nucleic Acid Electrophoresis and Blotting Market Size Growth (2018-2023)
4.5 Middle East & Africa Nucleic Acid Electrophoresis and Blotting Market Size Growth (2018-2023)
5 Americas
5.1 Americas Nucleic Acid Electrophoresis and Blotting Market Size by Country (2018-2023)
5.2 Americas Nucleic Acid Electrophoresis and Blotting Market Size by Type (2018-2023)
5.3 Americas Nucleic Acid Electrophoresis and Blotting Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Electrophoresis and Blotting Market Size by Region (2018-2023)
6.2 APAC Nucleic Acid Electrophoresis and Blotting Market Size by Type (2018-2023)
6.3 APAC Nucleic Acid Electrophoresis and Blotting Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nucleic Acid Electrophoresis and Blotting by Country (2018-2023)
7.2 Europe Nucleic Acid Electrophoresis and Blotting Market Size by Type (2018-2023)
7.3 Europe Nucleic Acid Electrophoresis and Blotting Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid Electrophoresis and Blotting by Region (2018-2023)
8.2 Middle East & Africa Nucleic Acid Electrophoresis and Blotting Market Size by Type (2018-2023)
8.3 Middle East & Africa Nucleic Acid Electrophoresis and Blotting Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nucleic Acid Electrophoresis and Blotting Market Forecast
10.1 Global Nucleic Acid Electrophoresis and Blotting Forecast by Regions (2024-2029)
10.1.1 Global Nucleic Acid Electrophoresis and Blotting Forecast by Regions (2024-2029)
10.1.2 Americas Nucleic Acid Electrophoresis and Blotting Forecast
10.1.3 APAC Nucleic Acid Electrophoresis and Blotting Forecast
10.1.4 Europe Nucleic Acid Electrophoresis and Blotting Forecast
10.1.5 Middle East & Africa Nucleic Acid Electrophoresis and Blotting Forecast
10.2 Americas Nucleic Acid Electrophoresis and Blotting Forecast by Country (2024-2029)
10.2.1 United States Nucleic Acid Electrophoresis and Blotting Market Forecast
10.2.2 Canada Nucleic Acid Electrophoresis and Blotting Market Forecast
10.2.3 Mexico Nucleic Acid Electrophoresis and Blotting Market Forecast
10.2.4 Brazil Nucleic Acid Electrophoresis and Blotting Market Forecast
10.3 APAC Nucleic Acid Electrophoresis and Blotting Forecast by Region (2024-2029)
10.3.1 China Nucleic Acid Electrophoresis and Blotting Market Forecast
10.3.2 Japan Nucleic Acid Electrophoresis and Blotting Market Forecast
10.3.3 Korea Nucleic Acid Electrophoresis and Blotting Market Forecast
10.3.4 Southeast Asia Nucleic Acid Electrophoresis and Blotting Market Forecast
10.3.5 India Nucleic Acid Electrophoresis and Blotting Market Forecast
10.3.6 Australia Nucleic Acid Electrophoresis and Blotting Market Forecast
10.4 Europe Nucleic Acid Electrophoresis and Blotting Forecast by Country (2024-2029)
10.4.1 Germany Nucleic Acid Electrophoresis and Blotting Market Forecast
10.4.2 France Nucleic Acid Electrophoresis and Blotting Market Forecast
10.4.3 UK Nucleic Acid Electrophoresis and Blotting Market Forecast
10.4.4 Italy Nucleic Acid Electrophoresis and Blotting Market Forecast
10.4.5 Russia Nucleic Acid Electrophoresis and Blotting Market Forecast
10.5 Middle East & Africa Nucleic Acid Electrophoresis and Blotting Forecast by Region (2024-2029)
10.5.1 Egypt Nucleic Acid Electrophoresis and Blotting Market Forecast
10.5.2 South Africa Nucleic Acid Electrophoresis and Blotting Market Forecast
10.5.3 Israel Nucleic Acid Electrophoresis and Blotting Market Forecast
10.5.4 Turkey Nucleic Acid Electrophoresis and Blotting Market Forecast
10.5.5 GCC Countries Nucleic Acid Electrophoresis and Blotting Market Forecast
10.6 Global Nucleic Acid Electrophoresis and Blotting Forecast by Type (2024-2029)
10.7 Global Nucleic Acid Electrophoresis and Blotting Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Bio-Rad
11.1.1 Bio-Rad Company Information
11.1.2 Bio-Rad Nucleic Acid Electrophoresis and Blotting Product Offered
11.1.3 Bio-Rad Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bio-Rad Main Business Overview
11.1.5 Bio-Rad Latest Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Information
11.2.2 Agilent Technologies Nucleic Acid Electrophoresis and Blotting Product Offered
11.2.3 Agilent Technologies Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Agilent Technologies Main Business Overview
11.2.5 Agilent Technologies Latest Developments
11.3 BioAtlas
11.3.1 BioAtlas Company Information
11.3.2 BioAtlas Nucleic Acid Electrophoresis and Blotting Product Offered
11.3.3 BioAtlas Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 BioAtlas Main Business Overview
11.3.5 BioAtlas Latest Developments
11.4 Cytiva
11.4.1 Cytiva Company Information
11.4.2 Cytiva Nucleic Acid Electrophoresis and Blotting Product Offered
11.4.3 Cytiva Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cytiva Main Business Overview
11.4.5 Cytiva Latest Developments
11.5 Lonza Group
11.5.1 Lonza Group Company Information
11.5.2 Lonza Group Nucleic Acid Electrophoresis and Blotting Product Offered
11.5.3 Lonza Group Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Lonza Group Main Business Overview
11.5.5 Lonza Group Latest Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Nucleic Acid Electrophoresis and Blotting Product Offered
11.6.3 Merck KGaA Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Merck KGaA Main Business Overview
11.6.5 Merck KGaA Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Nucleic Acid Electrophoresis and Blotting Product Offered
11.7.3 Qiagen Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 Takara Bio
11.8.1 Takara Bio Company Information
11.8.2 Takara Bio Nucleic Acid Electrophoresis and Blotting Product Offered
11.8.3 Takara Bio Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Takara Bio Main Business Overview
11.8.5 Takara Bio Latest Developments
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Information
11.9.2 Thermo Fisher Scientific Nucleic Acid Electrophoresis and Blotting Product Offered
11.9.3 Thermo Fisher Scientific Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Thermo Fisher Scientific Main Business Overview
11.9.5 Thermo Fisher Scientific Latest Developments
11.10 Promega Corporation
11.10.1 Promega Corporation Company Information
11.10.2 Promega Corporation Nucleic Acid Electrophoresis and Blotting Product Offered
11.10.3 Promega Corporation Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Promega Corporation Main Business Overview
11.10.5 Promega Corporation Latest Developments
11.11 Hoefer
11.11.1 Hoefer Company Information
11.11.2 Hoefer Nucleic Acid Electrophoresis and Blotting Product Offered
11.11.3 Hoefer Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Hoefer Main Business Overview
11.11.5 Hoefer Latest Developments
11.12 Sebia Group
11.12.1 Sebia Group Company Information
11.12.2 Sebia Group Nucleic Acid Electrophoresis and Blotting Product Offered
11.12.3 Sebia Group Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sebia Group Main Business Overview
11.12.5 Sebia Group Latest Developments
11.13 Randox Laboratories
11.13.1 Randox Laboratories Company Information
11.13.2 Randox Laboratories Nucleic Acid Electrophoresis and Blotting Product Offered
11.13.3 Randox Laboratories Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Randox Laboratories Main Business Overview
11.13.5 Randox Laboratories Latest Developments
11.14 Helena Laboratories Corporation
11.14.1 Helena Laboratories Corporation Company Information
11.14.2 Helena Laboratories Corporation Nucleic Acid Electrophoresis and Blotting Product Offered
11.14.3 Helena Laboratories Corporation Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Helena Laboratories Corporation Main Business Overview
11.14.5 Helena Laboratories Corporation Latest Developments
11.15 ELITechGroup
11.15.1 ELITechGroup Company Information
11.15.2 ELITechGroup Nucleic Acid Electrophoresis and Blotting Product Offered
11.15.3 ELITechGroup Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 ELITechGroup Main Business Overview
11.15.5 ELITechGroup Latest Developments
11.16 LabRepCo
11.16.1 LabRepCo Company Information
11.16.2 LabRepCo Nucleic Acid Electrophoresis and Blotting Product Offered
11.16.3 LabRepCo Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 LabRepCo Main Business Overview
11.16.5 LabRepCo Latest Developments
11.17 Abcam
11.17.1 Abcam Company Information
11.17.2 Abcam Nucleic Acid Electrophoresis and Blotting Product Offered
11.17.3 Abcam Nucleic Acid Electrophoresis and Blotting Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Abcam Main Business Overview
11.17.5 Abcam Latest Developments
12 Research Findings and Conclusion